Figure 1.
![Change in fructosamine. Changes in posttreatment values (adjusted mean ± SEM) from the common pretreatment value of 247 µmol/L (the covariate). Posttreatment adjusted mean ± SEM for the placebo (n = 24), RSVlow (n = 21), and RSVhigh (n = 21) groups were 242 ± 2.76 µmol/L, 244 ± 3.14 µmol/L, and 254 ± 2.95 µmol/L (ANCOVA P < 0.011). Post hoc Sidak multiple comparisons showed fructosamine level was significantly increased in the RSVhigh group compared with that of the placebo group [mean difference, 11.8 µmol/L (95% CI, 2.04 to 21.5 µmol/L)]. *P < 0.013. Symbols represent the study groups: placebo (○), RSVlow (□), and RSVhigh (Δ). Pre, pretreatment; Post, posttreatment.](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jcem/102/5/10.1210_jc.2016-2160/2/jc.2016-2160f1.jpeg?Expires=1750531733&Signature=QwNEbK9opojvAwPNhNKjp4E~WMpe3q6pj6XADmenJTrUu9wpotr4HhEx8C~Zw~hIrhtVHnKn9IOshzsEoCgEvqILM~KFhyW1k8nL~WrDsqCfuI-1mwgeAV5ur7RMciBG0fKZl9Kv3C0eIgYHhR7wsuo4qkQMniygEBzNCtAzdUq3gfSBaXSaFw6d~sf~upf1Ums5QgjGAdOcxrQdKAWL1wOTu85sy7dkPc5kKy3YAILtuP8A9rzLfQEd10bAhdj4u9N5udNEhmkDSmXH8e8TG2tldN25MhLQkD4bzpaVCEvgSKYLqPWCD8bOxe8JjCrgA7RbGRyOSJsBXo8nWwJxVg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Change in fructosamine. Changes in posttreatment values (adjusted mean ± SEM) from the common pretreatment value of 247 µmol/L (the covariate). Posttreatment adjusted mean ± SEM for the placebo (n = 24), RSVlow (n = 21), and RSVhigh (n = 21) groups were 242 ± 2.76 µmol/L, 244 ± 3.14 µmol/L, and 254 ± 2.95 µmol/L (ANCOVA P < 0.011). Post hoc Sidak multiple comparisons showed fructosamine level was significantly increased in the RSVhigh group compared with that of the placebo group [mean difference, 11.8 µmol/L (95% CI, 2.04 to 21.5 µmol/L)]. *P < 0.013. Symbols represent the study groups: placebo (○), RSVlow (□), and RSVhigh (Δ). Pre, pretreatment; Post, posttreatment.
